Ebola vaccine and treatment
Copyright policy )Ebola vaccine and treatment
Filoviruses (Ebola and Marburg viruses) cause severe hemorrhagic fever in humans and nonhuman primates. No effective prophylaxis or treatment for filovirus diseases is yet commercially available. The recent outbreak of Ebola virus disease in West Africa has accelerated efforts to develop anti-Ebola virus prophylaxis and treatment, and unapproved drugs were indeed used for the treatment of patients during the outbreak. This article reviews previous researches and the latest topics on vaccine and therapy for Ebola virus disease.
- Hokkaido Bunkyo University Japan
- Hokkaido University Japan
Membrane Glycoproteins, Virulence, Cells, Hemorrhagic Fever, Ebola, Ebolavirus, Disease Outbreaks, Africa, Western, Drug Discovery, Host-Pathogen Interactions, Animals, Humans, Amino Acid Sequence, Ebola Vaccines, Phylogeny
Membrane Glycoproteins, Virulence, Cells, Hemorrhagic Fever, Ebola, Ebolavirus, Disease Outbreaks, Africa, Western, Drug Discovery, Host-Pathogen Interactions, Animals, Humans, Amino Acid Sequence, Ebola Vaccines, Phylogeny
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!